Enhanced response to basiliximab in a patient with aplastic anemia after treatment with standard immunosuppression

Sustained long-term hematologic recovery

Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy

✍ J.P. Maciejewski; S. Kim; E. Sloand; C. Selleri; N.S. Young 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Previously, we reported that patients with aplastic anemia (AA) have profoundly decreased numbers of hematopoietic progenitor and stem cells as measured in the longterm culture initiating cell (LTC-IC) assay (Blood 1996;88:1983-1991). We now present results of a long-term prospective study of LTC-IC